These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3. Kobayashi S; Teramura M; Hoshino S; Motoji T; Oshimi K; Mizoguchi H Br J Haematol; 1993 Apr; 83(4):539-44. PubMed ID: 7686030 [TBL] [Abstract][Full Text] [Related]
9. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders. Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461 [TBL] [Abstract][Full Text] [Related]
10. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components. Wang SA; Hutchinson L; Tang G; Chen SS; Miron PM; Huh YO; Jones DM; Bueso-Ramos C; Verstovsek S; Medeiros LJ; Miranda RN Am J Hematol; 2013 Mar; 88(3):219-24. PubMed ID: 23440662 [TBL] [Abstract][Full Text] [Related]
14. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Hibbin JA; Njoku OS; Matutes E; Lewis SM; Goldman JM Br J Haematol; 1984 Jul; 57(3):495-503. PubMed ID: 6743569 [TBL] [Abstract][Full Text] [Related]
15. Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia. Briggs M; Adams JA; Brereton ML; Burgess R; Hyde K; Lenehan H; Yin JA Br J Haematol; 2001 Dec; 115(3):563-8. PubMed ID: 11736936 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of in vitro growth pattern of megakaryocyte progenitors (CFU-M) in myeloproliferative disorders. Hamaguchi H; Takano N; Sakamaki H; Enokihara H; Saito K; Furusawa S; Shishido H Eur J Haematol; 1988 Aug; 41(2):163-9. PubMed ID: 3410010 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of mastocytosis: an emerging challenge in applied hematology. Valent P Hematology Am Soc Hematol Educ Program; 2015; 2015():98-105. PubMed ID: 26637707 [TBL] [Abstract][Full Text] [Related]
18. Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7. Agis H; Krauth MT; Mosberger I; Müllauer L; Simonitsch-Klupp I; Schwartz LB; Printz D; Böhm A; Fritsch G; Horny HP; Valent P J Clin Pathol; 2006 Apr; 59(4):396-402. PubMed ID: 16461568 [TBL] [Abstract][Full Text] [Related]
19. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF). Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893 [TBL] [Abstract][Full Text] [Related]
20. Mastocytosis: state of the art. Horny HP; Sotlar K; Valent P Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]